StockData

Rafael Holdings, Inc. (RFL) stock

RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 5/30
$0.91−0.06 (-5.84%)

Close on Nov 17, 2026Market cap $47.67MP/E –Yield –

Rafael price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Rafael's price to sales ratio was 64.1× on Nov 11, 2026, against 37.9× a year earlier. Over the last 5 years it ranged from 16.0× to 176.4×, with a median of 69.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202664.1×+23.1
2025Dec 31, 202541.0×−16.0
2024Dec 31, 202456.9×−97.8
2023Dec 29, 2023154.7×+20.3
2022Dec 30, 2022134.5×+106.1
2021Dec 31, 202128.4×−49.2
2020Dec 31, 202077.6×+26.8
2019Dec 31, 201950.8×+28.3
2018Dec 31, 201822.5×–

More Rafael figures

See a number that looks wrong?